Inventor
BUMCROT DAVID
US30 patents
⚠️ This page may combine multiple inventors who share the name “BUMCROT DAVID”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALNYLAM PHARMACEUTICALS INC
19 patentsUS7749978B2Jul 6, 2010
Compositions and methods for inhibiting expression of Huntingtin gene
ALNYLAM PHARMACEUTICALS INC113 citations99
US7718629B2May 18, 2010
Compositions and methods for inhibiting expression of Eg5 gene
ALNYLAM PHARMACEUTICALS INC241 citations99
US7320965B2Jan 22, 2008
Compositions and methods for inhibiting expression of Huntingtin gene
ALNYLAM PHARMACEUTICALS INC208 citations99
US8809516B2Aug 19, 2014
Therapeutic compositions
ALNYLAM PHARMACEUTICALS INC43 citations98
US10273477B2Apr 30, 2019
Therapeutic compositions
ALNYLAM PHARMACEUTICALS INC11 citations93
US9708615B2Jul 18, 2017
Therapeutic compositions
ALNYLAM PHARMACEUTICALS INC10 citations93
US9222091B2Dec 29, 2015
Therapeutic compositions
ALNYLAM PHARMACEUTICALS INC8 citations93
US7595306B2Sep 29, 2009
Method of treating neurodegenerative disease
ALNYLAM PHARMACEUTICALS INC23 citations92
US10669544B2Jun 2, 2020
Therapeutic compositions
ALNYLAM PHARMACEUTICALS INC6 citations84
US9879261B2Jan 30, 2018
Serpina1 siRNAs: compositions of matter and methods of treatment
ALNYLAM PHARMACEUTICALS INC10 citations84
US11530408B2Dec 20, 2022
Therapeutic compositions
ALNYLAM PHARMACEUTICALS INC1 citations73
US11198876B2Dec 14, 2021
Compositions and methods for inhibiting expression of TMPRSS6 gene
ALNYLAM PHARMACEUTICALS INC3 citations73
US10935917B2Mar 2, 2021
Serpina1 siRNAs: compositions of matter and methods of treatment
ALNYLAM PHARMACEUTICALS INC2 citations73
US12559755B2Feb 24, 2026
Compositions and methods for inhibiting expression of TMPRSS6 gene
ALNYLAM PHARMACEUTICALS INC0 citations62
US12031133B2Jul 9, 2024
GNAQ targeted dsRNA compositions and methods for inhibiting expression
ALNYLAM PHARMACEUTICALS INC0 citations62
US10954516B2Mar 23, 2021
GNAQ targeted dsRNA compositions and methods for inhibiting expression
ALNYLAM PHARMACEUTICALS INC0 citations62
US9963700B2May 8, 2018
GNAQ targeted dsRNA compositions and methods for inhibiting expression
ALNYLAM PHARMACEUTICALS INC1 citations62
US9057069B2Jun 16, 2015
Compositions and methods for inhibiting expression of Eg5 gene
ALNYLAM PHARMACEUTICALS INC0 citations52
US9566295B2Feb 14, 2017
GNAQ targeted dsRNA compositions and methods for inhibiting expression
ALNYLAM PHARMACEUTICALS INC0 citations51
BUMCROT DAVID
4 patentsUS8124752B2Feb 28, 2012
Compositions and methods for inhibiting expression of the MYC gene
BUMCROT DAVID37 citations92
US9175290B2Nov 3, 2015
Compositions and methods for inhibiting expression of TMPRSS6 gene
BUMCROT DAVID8 citations83
US9006197B2Apr 14, 2015
Compositions and methods for inhibiting expression of Eg5 and VEGF genes
BUMCROT DAVID4 citations72
US8859516B2Oct 14, 2014
Lipid formulated compositions and methods for inhibiting expression of Eg5 and VEGF genes
BUMCROT DAVID0 citations48